CureVac Swiss AG Initiates Rolling Submission Process for mRNA-based COVID-19 Vaccine Candidate, CVnCoV, with Swissmedic
Rolling submission to accelerate time to marketing authorization of CVnCoV in Switzerland Review process started…
Vaccine
Humanity Supersedes Technology with Covid Vaccines
Lessons from the most important tech adoption of our century: the COVID-19 vaccine By Cameron…
CureVac’s COVID-19 Vaccine Candidate, CVnCoV, Demonstrated Efficient Protection of Non-Human Primates During SARS-CoV-2 Challenge Infection
Data provided further evidence on immunogenicity and protective efficacy of CVnCoV ∙ Induction of robust…